These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 35833395)

  • 1. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
    Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Trial of Mycobacterium w in Severe Presumed Gram-Negative Sepsis.
    Sehgal IS; Basumatary NM; Dhooria S; Prasad KT; Muthu V; Aggarwal AN; Pal A; Desai M; Chaudhry D; Supe PD; Kurmi P; Choudhuri R; Shah C; Agarwal R
    Chest; 2021 Oct; 160(4):1282-1291. PubMed ID: 33852919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Efficacy and Safety of Remdesivir among Hospitalised Adult Patients with RT PCR Confirmed COVID 19 Requiring ICU Care in Kalyana Karnataka.
    Waddankeri S; Hesarur SS; Hiremath SS; A S; Ar S; Raikod BP; Kinagi S; Biradar S; Belli B; Melkundi S; Singh G
    J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study.
    Elhadi M; Alsoufi A; Abusalama A; Alkaseek A; Abdeewi S; Yahya M; Mohammed A; Abdelkabir M; Huwaysh M; Amkhatirah E; Alshorbaji K; Khel S; Gamra M; Alhadi A; Abubaker T; Anaiba M; Elmugassabi M; Binnawara M; Khaled A; Zaid A; Msherghi A
    PLoS One; 2021; 16(4):e0251085. PubMed ID: 33930079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Mycobacterium w for the Treatment of COVID-19: An Observational Study.
    Ingale A; Ingale F; Kunwar B; Ahmed S; Salvi K; Chavan V; Sontakke M; Chandrashekhar T
    J Assoc Physicians India; 2021 Jan; 69(1):19-22. PubMed ID: 34227770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Experience of High-dose Intravenous
    Patel PS; Patel S; Shah V; Aswani V; Narwaria M
    Indian J Crit Care Med; 2021 Sep; 25(9):1066-1068. PubMed ID: 34963729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy.
    Popadic V; Klasnja S; Milic N; Rajovic N; Aleksic A; Milenkovic M; Crnokrak B; Balint B; Todorovic-Balint M; Mrda D; Zdravkovic D; Toskovic B; Brankovic M; Markovic O; Bjekic-Macut J; Djuran P; Memon L; Brajkovic M; Todorovic Z; Hadzi-Djokic J; Jovanovic I; Nikolic D; Zdravkovic M
    Oxid Med Cell Longev; 2021; 2021():6648199. PubMed ID: 33968298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis.
    Ismail K; Bensasi H; Taha A; Nazir A; Abdelkhalek M; Mohamed W; Lodhe D; Buschbeck S; Bauer M; Sakr Y
    PLoS One; 2021; 16(10):e0251687. PubMed ID: 34679109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulinastatin Add-on to Standard of Care in Critically Ill COVID-19 Patients: A Multicenter, Retrospective Study.
    Mehta Y; Zirpe K; Dixit S; Ansari A; Mehta C; Deshmukh A; Ambapkar S; Ambapkar S; Joshi M; Joshi A; Bathija M; Shah M
    J Assoc Physicians India; 2023 Feb; 71(2):11-12. PubMed ID: 37354467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory predictors at ICU admission affecting course of illness and mortality rates in a tertiary COVID-19 center.
    Kukoč A; Mihelčić A; Miko I; Romić A; Pražetina M; Tipura D; Drmić Ž; Čučković M; Ćurčić M; Blagaj V; Lasić H; Dolenc E; Hleb S; Almahariq H; Peršec J; Šribar A
    Heart Lung; 2022; 53():1-10. PubMed ID: 35104727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls.
    Jamous F; Meyer N; Buus D; Ateeli H; Taggart K; Hanson T; Alzoubaidi M; Nazir J; Devasahayam J
    S D Med; 2020 Jul; 73(7):312-317. PubMed ID: 32805781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hyperchloremia on inflammatory markers, serum creatinine, hemoglobin, and outcome in critically ill patients with COVID-19 infection.
    Al Qahtani SY
    J Med Life; 2023 May; 16(5):699-706. PubMed ID: 37520482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.